Advisory Committee Meeting to Review NDA for Omecamtiv Mecarbil Scheduled for December 13, 2022; PDUFA Target Action Date Set for February 28, 2023
Company Revises 2022 Financial Guidance; Reduces Projected Spending for 2022
https://finance.yahoo.com/news/cytokinetics-reports-second-quarter-2022-200000742.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.